Press release
The Antiplatelet Drugs Market To Thrive Backed By Wearable Technology
Get Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/17062
Antiplatelet drugs are widely used in heart attack patients because most heart attacks are caused by blood clots in the arteries that supply the heart muscle. It is also used for patients undergoing surgical procedures, such as angioplasty, where a tube called a stent is inserted to unblock an artery .
Antiplatelet Drugs market is expected to drive during the forecast period owing to increasing organic and inorganic growth within the industry. In addition, the generic market is also growing, revitalizing generic antiplatelet manufacturers. The amount the company spends on research and development is also expected to contribute to the revenue of the antiplatelet market in the future. For example, in February 2017, PLx Pharma published positive antiplatelet data for its Aspertec drug in the Journal of the American College of Cardiology (JACC). Now, researchers are focusing on analyzing pharmacodynamics and meta-analysis to determine if one drug has an advantage over another.
Request Table of Contents @ https://www.persistencemarketresearch.com/toc/17062
Antiplatelet Drugs Market: Segmentation
depending on the type of drug
• aspirin
• Clopidogrel
• tikageler
• Prasugrel
• dipyridamole
• ticlopidine
• Absiximab
• tirofiban
• Etc
Based on application
• myocardial infarction
• Percutaneous coronary intervention
• angioplasty
• arterial thrombosis
• dental surgery
• Etc
By end-user
• hospital
• clinic
• emergency service center
• outpatient surgery center
• Etc
Aspirin is a very well-known antiplatelet drug that has been used for a very long time. In addition to aspirin, there are three drugs that received FDA approval in the 1990s. Plavix in 1997, Ticlid in 1991, Aggrenox in 1999. After this series of drugs, Effient was approved by the FDA in 2009. Antiplatelet drugs are just one type of drug used to treat people with stroke and heart attack. Antiplatelet drugs are usually given along with other antithrombotic drugs, lifestyle changes, and non-drug treatments to keep the heart healthy .
Access Full Report @ https://www.persistencemarketresearch.com/checkout/17062
Geographically, the Antiplatelet Drugs market has been segmented into 5 regions including North America, Asia Pacific, Middle East & Africa, Latin America & Europe. North America is the region with the highest number of players starting clinical trials for antiplatelet drugs. There are also many academic universities that receive research grants to develop new product alternatives. For example, Kengreal, an intravenous antiplatelet drug developed by The Medicines Company, is FDA-approved. Asia Pacific is expected to lead during the forecast period as it is an economically developing country.
Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Antiplatelet Drugs Market To Thrive Backed By Wearable Technology here
News-ID: 2710906 • Views: …
More Releases from Persistence Market Research
Automotive Relay Market to Reach US$ 30.0 Billion by 2033 at 5.2% CAGR | Key Pla …
The automotive relay market plays a foundational role in modern vehicle electrical and electronic systems, enabling safe and efficient control of high-current circuits using low-power signals. Automotive relays are widely used across vehicles to manage functions such as lighting systems, power windows, fuel pumps, heating and cooling systems, starter motors, and advanced driver-assistance features. As vehicles evolve toward higher electrification and electronic integration, the importance of reliable relay systems has…
Decorative Exterior Materials Market Expected to Reach US$ 417.1 Billion by 2033 …
The decorative exterior materials market represents a vital segment of the global construction and building materials industry, encompassing products designed to enhance the visual appeal, durability, and functional performance of building exteriors. These materials include exterior paints and coatings, cladding systems, facade panels, decorative concrete, stone veneers, exterior tiles, architectural glass, and advanced composite materials. As buildings increasingly serve as expressions of architectural identity and brand value, decorative exterior materials…
Protein Purification Reagents Market Valued at US$ 11.6 Bn in 2026, Set for Stro …
The global protein purification reagents market has experienced robust growth and is expected to continue its upward trajectory in the coming years. The market, valued at USD 11.6 billion in 2026, is projected to reach USD 23.4 billion by 2033, growing at a compound annual growth rate (CAGR) of 10.5% during the forecast period. This growth is primarily driven by the expanding biopharmaceutical research sector, an increasing focus on protein-based…
Automotive Drum Brake Market to Reach US$ 7.9 Bn by 2033 at 4.3% CAGR | Persiste …
The global automotive drum brake market is witnessing steady growth due to its cost-effective, durable, and low-maintenance characteristics. Automotive drum brakes, traditionally used in passenger cars, commercial vehicles, and heavy-duty applications, continue to remain relevant despite the increasing adoption of disc brakes in premium segments. Their robust design and ability to withstand harsh operational conditions make them a preferred choice in emerging economies where affordability and reliability are primary factors…
More Releases for Antiplatelet
Antiplatelet Market Analysis 2024: Size, Share & Growth Report 2032
Allied Market Research added new research on Antiplatelet Market- Global Opportunity Analysis and Industry Forecast, 2022-2032. The Antiplatelet market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key players involved in the study are Glaxosmithkline, Abbott Laboratories, Genentech, Armetheon,…
Antiplatelet Market To Witness Strong Growth by 2032 | Astrazeneca, Novartis, Pf …
Allied Market Research added new research on Antiplatelet Market- Global Opportunity Analysis and Industry Forecast, 2022-2032. The Antiplatelet market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key players involved in the study are Glaxosmithkline, Abbott Laboratories, Genentech, Armetheon,…
Empowering Lives: Antiplatelet Drugs Market Trends
In 2023, the global antiplatelet drugs market reached an impressive value of USD 2.2 billion. This remarkable growth has been spurred by significant advancements in the pharmaceutical industry and a concerning increase in cases of thrombosis, which encompasses both arterial and venous conditions. As we look ahead to the forecast period of 2024-2032, the market is expected to continue its robust expansion, with a projected compound annual growth rate (CAGR)…
Antiplatelet Market: Advancements in Preventing Blood Clotting Disorders
Allied Market Research Analyst have added a new research study on Title Antiplatelet Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as Glaxosmithkline, Abbott Laboratories, Genentech, Armetheon Inc., Eli Lilly, Bayer AG, Daiichi Sankyo Co. Ltd., Merck, Johnson & Johnson, Novartis, and Pfizer Inc., F.Hoffmann-La Roche AG, Astrazeneca. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies…
Antiplatelet Drugs Market - Increasing incidence of cardiovascular diseases is e …
The report presents an in-depth assessment of the Antiplatelet Drugs Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses of…
Antiplatelet Drugs Market Size, Status, Global Demand and Growth Opportunities 2 …
The Global Antiplatelet Drugs Market report provides a detailed analysis of the market by end-user (replacement and OEM) and geography (APAC, Europe, MEA, North America, and South America). The report analyzes the market’s competitive landscape and offers information on several Antiplatelet Drugs including Eli Lilly, Alexion, Merck, Amgen, Bristol-Myers Squibb, Pfizer, Sanofi, Roche, Boehringer Ingelheim, GSK. The report also takes into account the impact of the novel COVID-19 pandemic on…
